Global Methotrexate Sales Market Report 2023

Publication ID:

PB501237849

Publication Date:

January 4, 2023

Pages:

115

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,000.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
Market Analysis and Insights: Global Methotrexate Market
Due to the COVID-19 pandemic, the global Methotrexate market size is estimated to be worth US$ 517.2 million in 2022 and is forecast to a readjusted size of US$ 624.6 million by 2029 with a CAGR of 2.7% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Methotrexate for Injection accounting for % of the Methotrexate global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Used for Cancers segment is altered to an % CAGR throughout this forecast period.
North America is the largest Methotrexate market with about 49% market share. China is follower, accounting for about 12% market share.
The key players are Teva Pharmaceutical Industries, Qualitestrx(DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical, Powerdone, Huiyu etc. Top 3 companies occupied about 65% market share.
Global Methotrexate Scope and Market Size
The global Methotrexate market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Methotrexate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.
Segment by Type
Methotrexate for Injection
Methotrexate Tablets
Segment by Application
Used for Cancers
Used for Rheumatoid Arthritis
Used for Other Diseases
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Teva Pharmaceutical Industries
Qualitestrx (DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Methotrexate Market Overview
1.1 Methotrexate Product Scope
1.2 Methotrexate Segment by Type
1.2.1 Global Methotrexate Sales by Type (2018 & 2022 & 2029)
1.2.2 Methotrexate for Injection
1.2.3 Methotrexate Tablets
1.3 Methotrexate Segment by Application
1.3.1 Global Methotrexate Sales Comparison by Application (2018 & 2022 & 2029)
1.3.2 Used for Cancers
1.3.3 Used for Rheumatoid Arthritis
1.3.4 Used for Other Diseases
1.4 Methotrexate Market Estimates and Forecasts (2018-2029)
1.4.1 Global Methotrexate Market Size in Value Growth Rate (2018-2029)
1.4.2 Global Methotrexate Market Size in Volume Growth Rate (2018-2029)
1.4.3 Global Methotrexate Price Trends (2018-2029)
2 Methotrexate Estimates and Forecasts by Region
2.1 Global Methotrexate Market Size by Region: 2018 VS 2022 VS 2029
2.2 Global Methotrexate Retrospective Market Scenario by Region (2018-2023)
2.2.1 Global Methotrexate Sales Market Share by Region (2018-2023)
2.2.2 Global Methotrexate Revenue Market Share by Region (2018-2023)
2.3 Global Methotrexate Market Estimates and Forecasts by Region (2024-2029)
2.3.1 Global Methotrexate Sales Estimates and Forecasts by Region (2024-2029)
2.3.2 Global Methotrexate Revenue Forecast by Region (2024-2029)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Methotrexate Estimates and Projections (2018-2029)
2.4.2 Europe Methotrexate Estimates and Projections (2018-2029)
2.4.3 China Methotrexate Estimates and Projections (2018-2029)
2.4.4 Japan Methotrexate Estimates and Projections (2018-2029)
2.4.5 Southeast Asia Methotrexate Estimates and Projections (2018-2029)
2.4.6 India Methotrexate Estimates and Projections (2018-2029)
3 Global Methotrexate Competition Landscape by Players
3.1 Global Top Methotrexate Players by Sales (2018-2023)
3.2 Global Top Methotrexate Players by Revenue (2018-2023)
3.3 Global Methotrexate Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Methotrexate as of 2022)
3.4 Global Methotrexate Average Price by Company (2018-2023)
3.5 Manufacturers Methotrexate Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Methotrexate Market Size by Type
4.1 Global Methotrexate Historic Market Review by Type (2018-2023)
4.1.1 Global Methotrexate Sales by Type (2018-2023)
4.1.2 Global Methotrexate Revenue by Type (2018-2023)
4.1.3 Global Methotrexate Price by Type (2018-2023)
4.2 Global Methotrexate Market Estimates and Forecasts by Type (2024-2029)
4.2.1 Global Methotrexate Sales Forecast by Type (2024-2029)
4.2.2 Global Methotrexate Revenue Forecast by Type (2024-2029)
4.2.3 Global Methotrexate Price Forecast by Type (2024-2029)
5 Global Methotrexate Market Size by Application
5.1 Global Methotrexate Historic Market Review by Application (2018-2023)
5.1.1 Global Methotrexate Sales by Application (2018-2023)
5.1.2 Global Methotrexate Revenue by Application (2018-2023)
5.1.3 Global Methotrexate Price by Application (2018-2023)
5.2 Global Methotrexate Market Estimates and Forecasts by Application (2024-2029)
5.2.1 Global Methotrexate Sales Forecast by Application (2024-2029)
5.2.2 Global Methotrexate Revenue Forecast by Application (2024-2029)
5.2.3 Global Methotrexate Price Forecast by Application (2024-2029)
6 United States Methotrexate Market Facts & Figures
6.1 United States Methotrexate Sales by Company
6.1.1 United States Methotrexate Sales by Company (2018-2023)
6.1.2 United States Methotrexate Revenue by Company (2018-2023)
6.2 United States Methotrexate Sales Breakdown by Type
6.2.1 United States Methotrexate Sales Breakdown by Type (2018-2023)
6.2.2 United States Methotrexate Sales Breakdown by Type (2024-2029)
6.3 United States Methotrexate Sales Breakdown by Application
6.3.1 United States Methotrexate Sales Breakdown by Application (2018-2023)
6.3.2 United States Methotrexate Sales Breakdown by Application (2024-2029)
7 Europe Methotrexate Market Facts & Figures
7.1 Europe Methotrexate Sales by Company
7.1.1 Europe Methotrexate Sales by Company (2018-2023)
7.1.2 Europe Methotrexate Revenue by Company (2018-2023)
7.2 Europe Methotrexate Sales Breakdown by Type
7.2.1 Europe Methotrexate Sales Breakdown by Type (2018-2023)
7.2.2 Europe Methotrexate Sales Breakdown by Type (2024-2029)
7.3 Europe Methotrexate Sales Breakdown by Application
7.3.1 Europe Methotrexate Sales Breakdown by Application (2018-2023)
7.3.2 Europe Methotrexate Sales Breakdown by Application (2024-2029)
8 China Methotrexate Market Facts & Figures
8.1 China Methotrexate Sales by Company
8.1.1 China Methotrexate Sales by Company (2018-2023)
8.1.2 China Methotrexate Revenue by Company (2018-2023)
8.2 China Methotrexate Sales Breakdown by Type
8.2.1 China Methotrexate Sales Breakdown by Type (2018-2023)
8.2.2 China Methotrexate Sales Breakdown by Type (2024-2029)
8.3 China Methotrexate Sales Breakdown by Application
8.3.1 China Methotrexate Sales Breakdown by Application (2018-2023)
8.3.2 China Methotrexate Sales Breakdown by Application (2024-2029)
9 Japan Methotrexate Market Facts & Figures
9.1 Japan Methotrexate Sales by Company
9.1.1 Japan Methotrexate Sales by Company (2018-2023)
9.1.2 Japan Methotrexate Revenue by Company (2018-2023)
9.2 Japan Methotrexate Sales Breakdown by Type
9.2.1 Japan Methotrexate Sales Breakdown by Type (2018-2023)
9.2.2 Japan Methotrexate Sales Breakdown by Type (2024-2029)
9.3 Japan Methotrexate Sales Breakdown by Application
9.3.1 Japan Methotrexate Sales Breakdown by Application (2018-2023)
9.3.2 Japan Methotrexate Sales Breakdown by Application (2024-2029)
10 Southeast Asia Methotrexate Market Facts & Figures
10.1 Southeast Asia Methotrexate Sales by Company
10.1.1 Southeast Asia Methotrexate Sales by Company (2018-2023)
10.1.2 Southeast Asia Methotrexate Revenue by Company (2018-2023)
10.2 Southeast Asia Methotrexate Sales Breakdown by Type
10.2.1 Southeast Asia Methotrexate Sales Breakdown by Type (2018-2023)
10.2.2 Southeast Asia Methotrexate Sales Breakdown by Type (2024-2029)
10.3 Southeast Asia Methotrexate Sales Breakdown by Application
10.3.1 Southeast Asia Methotrexate Sales Breakdown by Application (2018-2023)
10.3.2 Southeast Asia Methotrexate Sales Breakdown by Application (2024-2029)
11 India Methotrexate Market Facts & Figures
11.1 India Methotrexate Sales by Company
11.1.1 India Methotrexate Sales by Company (2018-2023)
11.1.2 India Methotrexate Revenue by Company (2018-2023)
11.2 India Methotrexate Sales Breakdown by Type
11.2.1 India Methotrexate Sales Breakdown by Type (2018-2023)
11.2.2 India Methotrexate Sales Breakdown by Type (2024-2029)
11.3 India Methotrexate Sales Breakdown by Application
11.3.1 India Methotrexate Sales Breakdown by Application (2018-2023)
11.3.2 India Methotrexate Sales Breakdown by Application (2024-2029)
12 Company Profiles and Key Figures in Methotrexate Business
12.1 Teva Pharmaceutical Industries
12.1.1 Teva Pharmaceutical Industries Corporation Information
12.1.2 Teva Pharmaceutical Industries Business Overview
12.1.3 Teva Pharmaceutical Industries Methotrexate Sales, Revenue and Gross Margin (2018-2023)
12.1.4 Teva Pharmaceutical Industries Methotrexate Products Offered
12.1.5 Teva Pharmaceutical Industries Recent Development
12.2 Qualitestrx (DAVA Pharmaceuticals)
12.2.1 Qualitestrx (DAVA Pharmaceuticals) Corporation Information
12.2.2 Qualitestrx (DAVA Pharmaceuticals) Business Overview
12.2.3 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Sales, Revenue and Gross Margin (2018-2023)
12.2.4 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Products Offered
12.2.5 Qualitestrx (DAVA Pharmaceuticals) Recent Development
12.3 Pfizer (Hospira)
12.3.1 Pfizer (Hospira) Corporation Information
12.3.2 Pfizer (Hospira) Business Overview
12.3.3 Pfizer (Hospira) Methotrexate Sales, Revenue and Gross Margin (2018-2023)
12.3.4 Pfizer (Hospira) Methotrexate Products Offered
12.3.5 Pfizer (Hospira) Recent Development
12.4 Roxane Laboratories
12.4.1 Roxane Laboratories Corporation Information
12.4.2 Roxane Laboratories Business Overview
12.4.3 Roxane Laboratories Methotrexate Sales, Revenue and Gross Margin (2018-2023)
12.4.4 Roxane Laboratories Methotrexate Products Offered
12.4.5 Roxane Laboratories Recent Development
12.5 Sine
12.5.1 Sine Corporation Information
12.5.2 Sine Business Overview
12.5.3 Sine Methotrexate Sales, Revenue and Gross Margin (2018-2023)
12.5.4 Sine Methotrexate Products Offered
12.5.5 Sine Recent Development
12.6 Maoxiang
12.6.1 Maoxiang Corporation Information
12.6.2 Maoxiang Business Overview
12.6.3 Maoxiang Methotrexate Sales, Revenue and Gross Margin (2018-2023)
12.6.4 Maoxiang Methotrexate Products Offered
12.6.5 Maoxiang Recent Development
12.7 LingNan Pharmaceutical
12.7.1 LingNan Pharmaceutical Corporation Information
12.7.2 LingNan Pharmaceutical Business Overview
12.7.3 LingNan Pharmaceutical Methotrexate Sales, Revenue and Gross Margin (2018-2023)
12.7.4 LingNan Pharmaceutical Methotrexate Products Offered
12.7.5 LingNan Pharmaceutical Recent Development
12.8 Powerdone
12.8.1 Powerdone Corporation Information
12.8.2 Powerdone Business Overview
12.8.3 Powerdone Methotrexate Sales, Revenue and Gross Margin (2018-2023)
12.8.4 Powerdone Methotrexate Products Offered
12.8.5 Powerdone Recent Development
12.9 Huiyu
12.9.1 Huiyu Corporation Information
12.9.2 Huiyu Business Overview
12.9.3 Huiyu Methotrexate Sales, Revenue and Gross Margin (2018-2023)
12.9.4 Huiyu Methotrexate Products Offered
12.9.5 Huiyu Recent Development
13 Methotrexate Manufacturing Cost Analysis
13.1 Methotrexate Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Methotrexate
13.4 Methotrexate Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Methotrexate Distributors List
14.3 Methotrexate Customers
15 Market Dynamics
15.1 Methotrexate Industry Trends
15.2 Methotrexate Market Drivers
15.3 Methotrexate Market Challenges
15.4 Methotrexate Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

Companies Mentioned:

Teva Pharmaceutical Industries
Qualitestrx (DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂